Microplasmin: Ex vivo characterization of its activity in porcine vitreous

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 2, 2009, Pages 814-819

  De Smet, Marc D ^a,b   Valmaggia, Christophe ^a,c   Zarranz Ventura, Javier ^d   Willekens, Ben ^e  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MIDDELHEIM HOSPITAL   (Belgium)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^d UNIVERSITY OF NAVARRA   (Spain)

^e NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MICROPLASMIN; PLASMIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEHYDRATION; DRUG ACTIVITY; ENZYME ACTIVITY; EX VIVO STUDY; EXPERIMENTAL PIG; HISTOPATHOLOGY; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; VITREOUS BODY DETACHMENT; ANIMAL; ANIMAL MODEL; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; PATHOLOGY; RETINA; SWINE; TIME; ULTRASTRUCTURE; VITREOUS BODY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; PEPTIDE FRAGMENTS; PLASMIN; RECOMBINANT PROTEINS; RETINA; SWINE; TIME FACTORS; VITREOUS BODY; VITREOUS DETACHMENT;

EID: 59449106074     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2185     Document Type: Article

References (24)

1. Bhisitkul RB. Anticipation for enzymatic vitreolysis. Br J Ophthalmol. 2001;85:1-3.
2. Trese MT. Enzymatic vitreous surgery. Semin Ophthalmol. 2000; 15:116-121.
3. Sebag J. Is pharmacologic vitreolysis brewing? Retina. 2002;22: 1-3.
4. Davis MD. Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol. 1965;74:741-751.
5. Foos RY, Kreiger AE, Forsythe AB, Zakka KA. Posterior vitreous detachment in diabetic subjects. Ophthalmology. 1980;87:122-128.
6. Akiba J, Arzabe CW, Trempe CL. Posterior vitreous detachment and neovascularization in diabetic retinopathy. Ophthalmology. 1990;97:889-891.
7. Johnson MW. Perifoveal vitreous detachment and its macular complications. Tr Am Ophthalmol Soc. 2005;103:537-567.
8. O'Neill R, Shea M. The effects of bacterial collagenase in rabbit vitreous. Can J Ophthalmol. 1973;8:366 -370.
9. Kuppermann BD, Thomas EL, de Smet MD, Grillone LR, The Vitrase for Vitreous Hemorrhage Study Groups. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol. 2005;140:573-584.
10. Tezel TH, Del Priore LV, Kaplan HJ. Posterior vitreous detachment with dispase. Retina. 1998;18:7-15.
11. Oliveira LB, Meyer CH, Kumar J, et al. RGD peptide-assisted vitrectomy to facilitate induction of a posterior vitreous detachment: a new principle in pharmacological vitreolysis. Curr Eye Res. 2002;25:333-340.
12. Gandorfer A, Putz E, Wege-Lüssen U, Grüterich M, Ulbig M, Kampik A. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol. 2001;85:6 -10.
13. Gandorfer A, Ulbig M, Kampik A. Plasmin-assisted vitrectomy eliminates cortical vitreous remnants. Eye. 2002;16:95-97.
14. Gandorfer A, Rohleder M, Sethi C, et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci. 2004; 45:641-647.
15. Gandorfer A, Kampik A. Intrasurgical plasmin enzyme in diabetic macular edema. Am J Ophthalmol. 2005;139:949.
16. Gandorfer A, Priglinger S, Schebitz K, et al. Vitreous morphology of plasmin treated human eyes. Am J Ophthalmol. 2002;133:156-159.
17. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmology. 2000;107:1607-1611.
18. Hikichi T, Yanagiya N, Kado M, Akiba J, Yoshida A. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina. 1999;19:55-58.
19. Margherio AR, Margherio RR, Hartzer M, Trese MT, Williams GA, Ferrone PJ. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology. 1998;105:1617-1620.
20. Nagai N, Demarsin E, Van Hoef B, et al. Recombinant human microplasmin: production and potential therapeutic properties. J Thrombosis Haemost. 2003;1:307-313.
21. Sakuma T, Tanaka M, Mizota A, Inoue J, Pakola S. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. Invest Ophthalmol Vis Sci. 2005;46:3295-3299.
22. Verstraeten TC, Chapman C, Hartzer M, Winkler BS, Trese MT, Williams GA. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol. 1993;111:849-854.
23. Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Ret Eye Res. 2000;19:323-344.
24. Pluen A, Netti PA, Jain RK, Berk DA. Diffusion of macromolecules in agarose gels: comparison of linear and globular configurations. Biophys J. 1999;77:542-562.